Xiaoping Zou
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Hepatology top 2%
- Liver Disease and Transplantation
Papers in
-
- RNA modifications and cancer 15
- ATP Synthase and ATPases Research 11
- Cancer-related gene regulation 9
- Oncology 46
- Pancreatic and Hepatic Oncology Research 15
- Co-authors
- Guifang Xu (17 shared papers)Shuling Huang (14 shared papers)Zhangding Wang (5 shared papers)Shouyu Wang (4 shared papers)Qiang Wang (4 shared papers)Xiaoqi Zhang (13 shared papers)Ying Lv (32 shared papers)Shanshan Shen (30 shared papers)
- Journals
- Oncotarget (6 papers)European Journal of Gastroenterology & Hepatology (6 papers)Journal of Gastroenterology and Hepatology (5 papers)International Immunopharmacology (5 papers)Cell Biology International (4 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Xiaoping Zou
206 papers receiving 5.3k citations
Xiaoping Zou's Hit Papers
Peers
Comparison fields: 5 of 148
- Cancer Research 1.1k
- Hepatology 299
- Gastroenterology 192
- Molecular Biology 2.5k
- Oncology 911
Countries citing papers authored by Xiaoping Zou
This map shows the geographic impact of Xiaoping Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoping Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoping Zou more than expected).
Fields of papers citing papers by Xiaoping Zou
This network shows the impact of papers produced by Xiaoping Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoping Zou. The network helps show where Xiaoping Zou may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoping Zou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 212 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | METTL3-mediated m 6 A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance Hit paper breakdown → | 2019 | 641 |
| 2 | 2020 | 263 | |
| 3 | 2016 | 175 | |
| 4 | 2020 | 90 | |
| 5 | 2011 | 85 | |
| 6 | 2019 | 80 | |
| 7 | 2018 | 80 | |
| 8 | 2012 | 73 | |
| 9 | 2008 | 72 | |
| 10 | 2020 | 71 | |
| 11 | 2021 | 68 | |
| 12 | 2019 | 66 | |
| 13 | 2009 | 66 | |
| 14 | 2021 | 65 | |
| 15 | 2020 | 65 | |
| 16 | 2022 | 64 | |
| 17 | 2015 | 59 | |
| 18 | 2009 | 57 | |
| 19 | 2017 | 56 | |
| 20 | 2014 | 55 |
About Xiaoping Zou
Xiaoping Zou is a scholar working on Molecular Biology, Oncology, Surgery, Cancer Research and Hepatology, having authored 212 papers that have together received 5.4k indexed citations. Recurring topics across this work include Liver Disease and Transplantation (16 papers), Pancreatic and Hepatic Oncology Research (15 papers), RNA modifications and cancer (15 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (12 papers), ATP Synthase and ATPases Research (11 papers), Cancer Mechanisms and Therapy (10 papers), Cancer-related gene regulation (9 papers) and Cancer, Hypoxia, and Metabolism (9 papers). The work is most often cited by research in Cancer Research (1.1k citations), Hepatology (299 citations), Gastroenterology (192 citations), Molecular Biology (2.5k citations) and Oncology (911 citations). Xiaoping Zou has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Guifang Xu, Shuling Huang, Zhangding Wang, Shouyu Wang, Qiang Wang, Xiaoqi Zhang, Ying Lv, Shanshan Shen, Guifang Xu and Beicheng Sun. Their work appears in journals such as Oncotarget, European Journal of Gastroenterology & Hepatology, Journal of Gastroenterology and Hepatology, International Immunopharmacology and Cell Biology International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.